biostudies-literatureAuer PLNational Institute of Allergy and Infectious DiseasesHRSA HHSNHLBI NIH HHSNational Heart, Lung, and Blood InstituteNational Cancer InstituteNCI NIH HHSHealth Resources and Services AdministrationNIHNIH HHSOffice of Naval Research770-773https://www.ebi.ac.uk/biostudies/studies/S-EPMC10947828biostudies-literatureUnknown99(4)Overall survival probability for MDS patients who underwent allo-HCT and were matched to donors that are wild-type (red) and heterozygous (blue) for the rs111224634 SNP.American journal of hematologyDonor germ-line variants associate with outcomes of allogeneic hematopoietic stem cell transplantation in patients with myelodysplastic syndromes.PMC1094782875R60222C00011N00014‐17‐1‐2850U24 CA076518HHSH250201700006CU24CA076518K01 HL164972N00014‐23‐1‐2057N00014‐21‐1‐2954Farazi MZhang TAuer PLBolon YTDong JSaber WSpellman SRfalseDonor germ-line variants associate with outcomes of allogeneic hematopoietic stem cell transplantation in patients with myelodysplastic syndromes.Overall survival probability for MDS patients who underwent allo-HCT and were matched to donors that are wild-type (red) and heterozygous (blue) for the rs111224634 SNP.2024-01-01T00:00:00Z2024 Apr2026-06-01T05:13:27.384Z2025-06-25T03:04:16.94ZS-EPMC109478283833977310.1002/ajh.27243